| MONDAY |
| Morning Session | Megakaryocyte Development and Platelet Growth Factor |
| Discussion Leader: Jack Levin |
| Neil T. Williams, University of Melbourne
Growth of Megakaryocyte from Precursor Cells |
| Enrique Rabellino, Cornell University
Human Megakaryocyte Growth and Development |
| Thomas F. Deuel, Washington University School of Medicine
Platelet-Derived Growth Factor - Cellular Interactions |
| Robert D. Rosenberg, MIT
Release of Heparin-Like Molecules From Endothelial Cells By Platelet Endoglycosidase and Their Role in Regulating Smooth Muscle Cell Proliferation |
| Evening Session | Platelet Membranes and Functions |
| Discussion Leaders: Barry Collar and Ernst Luscher |
| Bruce Furie, N.E. Med. Center Hospital
Murine and Human Monoclonal Antibody to Human Platelets |
| Thomas Kunicki, Blood Center of Southeastern Wisconsin
Spatial Interactions of Glycoproteins |
| Yves LeGrand, Hospital Lariboisiere
Intact Platelet Membranes as Determined by Chemical Cross-Linking Reagents |
| J.P. Caen, University Paris VII
Platelet Binding to Macromolecular Components to Subendothelium |
| Neville Crawford, Royal College of England
Grey Platelet Syndrome, Megakaryocytes and Myelofibrosis |
| TUESDAY |
| Morning Session | Biosynthesis of Procoagulants |
| Discussion Leader: Gerald Fuller |
| Gerald R. Crabtree, NIH
Structural Relationships Among Rat Fibrinogen Genes |
| Sandra J. Degen, University of Washington
Human Prothrombin Gene |
| Susan C. Bock, Genentech, Inc.
At III Gene |
| Harold R. Roberts, University of N.C.
Interactions of Abnormal Factor IX Molecules |
| Howard Reisner, Universtiy of N.C.
Human Antibody to Factor IX as a Probe of Dysmorphic Factor IX Molecules |
| Evening Session | Fibrinolysis |
| Discussion Leader: Francis J. Castellino |
| David J. Loskutoff, Scripps Clinic & Research Foundation
Regulation of Fibrinolytic Activity by Cultured Endothelial Cells |
| Fletcher B. Taylor, University of Oklahoma
Regulation of Whole Blood Clot Lysis by Adherent Lymphocytes and Activated Protein C" |
| Fedor Bachmann, Center Hospital University, Vaudois
Physiologic Activation of Plasmingen |
| WEDNESDAY |
| Morning Session | Protein C" |
| Discussion Leader: Johan Stenflo |
| Charles T. Esmon, University of Oklahoma Health Sciences
Protein C": Activation Requirements and Cofactors |
| Philip C. Comp, University of Oklahoma
In Vivo Activation of Protein C" |
| John H. Griffin, Scripps Clinic & Research Foundation
Human Protein C" |
| Evening Session | Prothrombin and Its Conversion |
| Discussion Leader: Michael E. Nesheim |
| Barry Foster, Mayo Clinic and Paula B. Tracy, Mayo Clinic
Monoclonal Antibody Probes of Forms of Factor V |
| S. Paul Bajaj, UCSD Medical Center
Factor Va Processing and Interactions |
| Yale Nemerson, Mt. Sinai School of Medicine
Factor VII Zymogen and Regulator Molecule |
| David Kosow, American Red Cross Blood Services
Metal Ions in Prothrombin Activation |
| THURSDAY |
| Morning Session | Fibronectin, Thrombospondin and Platelets |
| Discussion Leader: Deane Mosher |
| Mark Ginsberg, Scripps Clinic & Research Foundation
Fibronection and Platelets |
| Henry S. Slater, Sidney Farber Cancer Institute
Thrombospodin |
| Lawrence L.K. Leung, Cornell University
Thrombospondin and Platelet Function |
| Evening Session | Platelet Activation Factor |
| Discussion Leader: R. Neal Pinckard, University of Texas |
| FRIDAY |
| Morning Session | Endothelium, Blood Cells and Clotting |
| Discussion Leader: Marc A. Shuman |
| Nancy L. Baenziger, Washington University School of Medicine
Receptor Regulation and Prostaglandin Synthesis |
| Robert I. Handin, Peter Brent Brigham Hospital
Interaction of Platelets with Vascular Neointima |
| Edward F. Plow, Research Inst. of Scripps Clinic
Leukocyte Elastase and Clotting |
